Loading...
Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital
BACKGROUND: Living donor liver transplantation (LDLT) is an established treatment not only for those with end-stage liver disease but for those with hepatocellular carcinoma (HCC) developing in cirrhotic liver. The aim of this study was to present a single-center experience of LDLT for HCC at the Un...
Saved in:
| Published in: | Hepatobiliary Surg Nutr |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
AME Publishing Company
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5075828/ https://ncbi.nlm.nih.gov/pubmed/27826554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2016.08.05 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|